Xiaofang Li

1.5k total citations
76 papers, 990 citations indexed

About

Xiaofang Li is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Xiaofang Li has authored 76 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 29 papers in Epidemiology and 21 papers in Oncology. Recurrent topics in Xiaofang Li's work include Fungal Infections and Studies (21 papers), Antifungal resistance and susceptibility (18 papers) and Nail Diseases and Treatments (11 papers). Xiaofang Li is often cited by papers focused on Fungal Infections and Studies (21 papers), Antifungal resistance and susceptibility (18 papers) and Nail Diseases and Treatments (11 papers). Xiaofang Li collaborates with scholars based in China, United States and Canada. Xiaofang Li's co-authors include Weida Liu, Xiaowei Zhou, Haixia Zheng, Qingzhong Xue, Dongmei Li, Yongnian Shen, Huan Mei, Shahid Jameel, Mohammad Zafrullah and Amy C Sherman and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Xiaofang Li

71 papers receiving 974 citations

Peers

Xiaofang Li
Comparison fields: 5 of 126
  • Infectious Diseases 355
  • Epidemiology 240
  • Molecular Biology 187
  • Hepatology 123
  • Oncology 122
Replace Qi Jin with:
Qi Jin China
Meera Gupta United States
Songmei Wang China
Noriyuki Watanabe Japan
Osbourne Quaye Ghana
Jingxia Zhang China
Jiayu Hu China
Carmen Mirabelli United States
William J. Reagan United States
Zhao Zhang China
Qi Jin China View profile →
Citations per field, relative to Xiaofang Li
Xiaofang Li · 1×
Citations per year, relative to Xiaofang Li
Xiaofang Li · 1×

Countries citing papers authored by Xiaofang Li

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Li more than expected).

Fields of papers citing papers by Xiaofang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Li. The network helps show where Xiaofang Li may publish in the future.

Co-authorship network of co-authors of Xiaofang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Li. A scholar is included among the top collaborators of Xiaofang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Li. Xiaofang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 6
3 1
4 1
5 1
6 2
7 5
8 20
9 5
10 5
11 2
12 6
13 8
14 5
15 2
16 13
17 1
18 6
19 1
20 5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026